New hope for inoperable esophageal cancer: drug combo aims to shrink tumors for surgery
Disease control
Recruiting now
This study is testing whether a drug called tislelizumab, combined with standard chemotherapy and radiation, can shrink advanced esophageal cancer tumors enough to make surgery possible. The goal is to control the disease and improve survival for patients who currently have no su…
Phase: PHASE2 • Sponsor: Ming-Yu Lien • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC